Brepocitinib 30 mg is more effective than placebo for skin-specific outcomes through 52 weeks of treatment among patients with dermatomyositis.

All enpatoran dosages were associated with improvements in skin manifestations of cutaneous lupus erythematosus and systemic lupus erythematosus.

Patients who use GLP-1 RAs have a significantly higher prevalence of nail disorders, including nail detachment, dyschromia, and fragility.

Dupilumab use among pediatric patients with moderate to severe AD is associated with a meaningful increase in weight percentiles.

Patients with NF1 have a greater prevalence of cherry angiomas than the general population and NF1 inactivation may contribute to their development.

The use of RHA4 is equivalent to that of an approved, active comparator for the treatment of midface volume deficiency through 52 weeks.

Out of all of the hematological parameters examined, only neutrophil-to-monocyte ratio was associated with ocular involvement in rosacea.

Pediatric patients with moderate to severe AD may have a reduced mean height and increased mean weight when compared with the general population.

Significant imbalances in sex hormones and oxidative stress were seen among women with severe acne vulgaris when compared with healthy controls.

Patients with HS who present to the emergency department vs ambulatory care for pain are significantly more likely to be prescribed opioids.

Laser therapy with intralesional triamcinolone was superior to laser monotherapy for hypertrophic scar, keloid, and post-burn scar treatment.

Research is needed on the real-world performance of clinical AI tools in dermatology, yet many patients use available consumer-facing tools.

Oral probiotic supplementation may be beneficial for skin hydration and barrier function, but additional research is needed.

Baseline clinical factors that predict treatment response varied by the type of therapy utilized among patients with plaque psoriasis.

Results of a systematic review and meta-analysis confirm the efficacy and safety of oral JAK inhibitors for the treatment of alopecia areata.

Low-dose micronized isotretinoin was an effective and safe therapy option for severe recalcitrant nodular acne in real-world settings.

Adults who adhere to healthy habits regarding alcohol consumption, smoking cessation, sleep, and physical activity have a lower risk for incident AD.

Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into federal law.

Both patients and health care providers regard the use of telemedicine for the management of systemic therapies for psoriasis and AD as positive.

Longitudinal histopathologic patterns of melanocytic lesions may be used to improve risk stratification for melanoma and other adverse outcomes.

Pruritus relief is the greatest treatment priority for those with moderate to severe AD, despite variations in priorities across patient subgroups.

A novel lidocaine-mixed HA gel was noninferior to an approved comparator for NLF correction among adults at 6 months post-treatment.

Delgocitinib cream has a significant dose-response relationship for achieving 75% improvement in EASI among patients with AD at 8 weeks.

A combined approach with dermoscopy and HH-RCM significantly reduces the rate of unnecessary diagnostic biopsies in patients with suspected BCC.

Though laboratory abnormalities are common with ritlecitinib therapy for alopecia areata, the majority are mild and not clinically significant.

No significant differences were noted in the biophysical characteristics of the scalp in women who used hijab vs those who did not.

Socrodeucitinib significantly reduced PASI scores at 12 weeks of treatment among adults with moderate to severe plaque psoriasis.

A skin biopsy is a common medical procedure in which a small sample of skin is removed for examination; aftercare can help reduce scarring.

Cellular grafting with ReCell results in superior repigmentation compared with standard tissue grafting in select populations with stable vitiligo.

Topical finasteride 0.25% is safe and effective when administered through a commercial spray or compounded solution for men with AGA.

Integrating RCM improves the diagnostic sensitivity and specificity for lesions on the head and neck when compared with dermoscopy alone.

The use of GLP-1 RAs was associated with lower rates of surgical procedures performed among patients with HS when compared with control patients.

The use of hair growth nutraceuticals was associated with significant improvements across various measures of hair growth in women.

Topline phase 3 INTerpath-001 trial results show adjuvant intismeran autogene plus pembrolizumab significantly improves RFS and DMFS in resected stage IIB-IV melanoma.

TikTok dermatologists are combating skin care misinformation, educating patients, and collaborating with peers to improve clinical practice.

The VAT technique with MTB staining may be an effective adjunctive method for the microscopic evaluation of superficial fungal skin infections.

Among patients with psoriasis, CAL/BDP PAD-cream was associated with the greatest rates of early clinical response across several efficacy measures.

Rituximab is efficacious for the treatment of PF, with a pooled complete remission rate of 75.0% and a median time to complete remission of 9 months.

Nemolizumab may be more effective across key pruritus and disease severity measures than dupilumab for patients with PN.

Early response to ivarmacitinib for the treatment of AD was associated with greater long-term efficacy compared with those without early response.

Treatment with dupilumab for 52 weeks is associated with improvement in height and BALP levels among pediatric patients with severe AD.

Tuberculosis risk among patients receiving systemic therapy for dermatologic diseases varied by treatment class and regional burden.

Among patients with AD, the risk for adverse effects with SGCs was time-dependent rather than dependent on the cumulative dose received.

Stapokibart is safe and effective for the treatment of moderate to severe AD despite a history of systemic treatment use.

OnabotulinumtoxinA for PP is associated with higher patient satisfaction across multiple clinical and psychosocial impact measures.

Patients with acne vulgaris who have increased use of social media often experience greater skin barrier damage and worse disease severity.

Disproportionality signals were identified for ADEs associated with apremilast spanning 24 SOCs, for a total of 60 apremilast-induced signals.